Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer

Radiation Oncology Investigations

Volumn 7, Issue 1, 1999, Pages 49-53

  Chen, L M ^a   Ignacio, L ^a   Jacobs, R ^b   Kozloff, M ^b   Telfer, M ^b   Elahi, R ^b   Evans, R ^b   Vijayakumar, S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

Author keywords

Chemoradiotherapy; Conformal radiation therapy; Lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE;

ARTICLE; BONE SCINTISCANNING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; ESOPHAGITIS; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; TREATMENT OUTCOME; TUMOR VOLUME;

ADMINISTRATION, ORAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0032995707     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:1<49::AID-ROI7>3.0.CO;2-8     Document Type: Article

References (16)

1. Parker S, Tong T, Bolden S, et al. Cancer statistics, 1997. CA 1997;47:5-27.
2. Martini N, Flehinger B, Nagasaki F, Hart B. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983;86:646-653.
3. Weisenburger T, Group LCS. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid carcinoma of the lung. N Engl J Med 1986;315:1377-1381.
4. Dillman R, Seagren S, Proprert K, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-945.
5. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524-530.
6. Sause W, Scott C, Taylor C, et al. Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer: Radiation Therapy Oncology Group and Eastern Cooperative Group. JNCI 1995;87:198-205.
7. Cancer AJCO. Manual for staging of cancer. Philadelphia: Lippincott; 1992.
8. Vijayakumar S, Low N, Chen G, et al. Beam's eye view-based photon radiotherapy I. Int J Radiat Oncol Biol Phys 1991;21:1575-1586.
9. Vijayakumar S, Myrianthopoulos L, Rosenberg I, et al. Optimization of radical radiotherapy with beam's eye view techniques for non small cell lung cancer. Int J Radiat Oncol Biol Phys 1991;21:779-788.
10. Sibley G, Mundt A, Shapiro C, et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:1001-1007.
11. Cox JD, Stetz J, Pajak TF. Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1995;31(5):1341-1346.
12. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. LeChavelier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung cancer. Lung Cancer 1994;10:239-244.
14. Vijayakumar S, Hellman S. Advances in radiation oncology. Lancet 1997;349:1-3.
15. Graham M, Purdy J, Emami B, et al. 3-D conformal radiotherapy for lung cancer. Front Radiat Ther Oncol 1996;29:188-198.
16. Lee J, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996;14:1055-1064.